This compound, an acetate ester derivative, serves as a pharmaceutical intermediate in the synthesis of ganciclovir, an antiviral agent. It is characterized by a purine ring system and multiple polar functional groups, reflecting its role in nucleoside analog manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 88110-89-8
Valganciclovir hydrochloride
pharmaceutical raw material
Valganciclovir
pharmaceutical raw material
Ganciclovir
pharmaceutical raw material
6-Bromoquinazoline-2,4-dione
pharmaceutical intermediate
Phthalimidoamlodipine
pharmaceutical intermediate
Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]-3-oxobutanoate
pharmaceutical intermediate
5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic acid ethyl ester
pharmaceutical intermediate
[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate
YKLKCCHLLFMWQE-UHFFFAOYSA-N
CC(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N